When a global pandemic strikes, it’s important to use the resources at your disposal to help others. According to a recent FiercePharma article, Swiss-based pharma giant Novartis is doing its part by promising zero profit from sales of 15 generic and over-the-counter drugs that manage COVID-19 symptoms in developing countries. The medicines, all from Novartis’ Sandoz unit, include widely used antibiotics and anti-inflammatory therapies and medications for cardiovascular and gastrointestinal diseases. On top of that, Novartis has pledged to donate $40 million to support communities affected by the pandemic.
Novartis to Forgo COVID-19 Profits in Developing Countries
The company’s generic division will offer 15 medicines at zero profit.
Jul 22, 2020
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this month to experience a breakthrough for life sciences products.
REGISTER NOW!